Comparison of two ways of using medications for preventing graft versus host disease after a half-matched stem cell transplant
Phase 2
- Conditions
- Health Condition 1: C920- Acute myeloblastic leukemia
- Registration Number
- CTRI/2024/06/068451
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients planned for haploidentical stem cell transplantation using post-transplant cyclophosphamide
Exclusion Criteria
1. Patients planned for T cell depleted haplodentical stem cell transplantation
2. Patients with significant organ dysfunction (creatinine above 2mg%, liver enzymes above 5 times the upper limit of normal, LV ejection fraction less than 40%)
3. Patients with active infection at the time of transplant
4. Patients undergoing a second transplant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method